Avitia improves cancer treatment via advanced molecular testing solutions, offers testing tools for use onsite, bioinformatics driven by AI.
Avitia has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Avitia's investors include PacBridge Capital Partners.
Avitia is headquartered in Montréal, Canada.
Avitia improves cancer treatment via advanced molecular testing solutions, offers testing tools for use onsite, bioinformatics driven by AI.
Avitia is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avitia — Funding & Investors." VCBacked, February 27, 2025, https://www.vcbacked.co/company/avitia. Accessed August 14, 2026.
VCBacked. (2025). Avitia — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/avitia
{{cite web |title=Avitia — Funding & Investors |url=https://www.vcbacked.co/company/avitia |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated